Progentec Diagnostics Cuts Lupus Classification Timeline by 80% In Virtual Study
- Progentec Diagnostics announced on May 27, 2025 in Oklahoma City that its virtual lupus classification program PROACTIVE identified SLE cases in just over one year.
- The program accelerated classification compared to the traditional five-to-seven-year timeline by using a fully digital, technology-enabled diagnostic journey.
- Participants underwent telehealth consultations, at-home phlebotomy for biomarker testing, and expert rheumatologist reviews based on established classification criteria to identify SLE and incomplete SLE.
- Dr. Timothy Niewold stated the study identified SLE participants in just over one year, while Dr. Eldon Jupe said classification time will accelerate further when applied to individuals under routine care.
- These findings, published in The Journal of Rheumatology, suggest digital tools and biomarker integration can enable faster, more accessible lupus classification and will guide future research and product development.
24 Articles
24 Articles

Progentec Diagnostics Cuts Lupus Classification Timeline by 80% In Virtual Study
Findings presented at LUPUS 2025 show virtual SLE Classification Program (PROACTIVE™) classified SLE cases in just over one year versus traditional five-to-seven-year timeline
Long-Term Anifrolumab Use Improves Quality of Life in Lupus
An extension trial revealed that long-term anifrolumab treatment improved health status and health-related quality of life in patients with moderate to severe systemic lupus erythematosus. Medscape Medical News
How Is Lupus Diagnosed?
May is Lupus Awareness Month. + Infographic text What is lupus? Lupus is a chronic condition where your body’s immune system attacks tissues and organs. 9 out of 10 people with lupus are female. Black, American Indian and Alaska Native women are 2–3x more likely to get lupus than white women. Almost 1 in 2 people with lupus are misdiagnosed at first It can take an average of 5 years from first seeking medical help to getting a lupus diagn…
Coverage Details
Bias Distribution
- 67% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage